Philips to acquire AI-powered cardiac diagnostic technology developer Cardiologs

[Image from Philips/Cardiologs]Royal Philips (NYSE:PHG) announced today that it signed an agreement to acquire Cardiologs and its artificial intelligence (AI)-based technology.

Amsterdam-based Philips said in a news release that France-based Cardiologs and its AI and cloud technology will further strengthen its cardiac monitoring and diagnostics offerings with innovative software, electrocardiogram (ECG) analysis and reporting services.

Financial terms were not disclosed for the transaction. The companies expect the deal to close in the coming months, subject to customary closing conditions.

Cardiologs’ offerings include a vendor-neutral heart disorder screener and ECG analysis applications based on machine learning algorithms. The company designed its technology to accelerate diagnostic reporting, decrease reporting errors and streamline clinician workflow and patient care. Its technology holds CE mark and FDA clearance for detecting cardiac arrhythm…

Read more
  • 0

Cardiologs touts results of AFib study

(Image courtesy of Cardiologs)

Artificial intelligence diagnostics company Cardiologs today announced the results of a clinical study showing its AI-based ECG analysis software “significantly” reduces the rate of false-positive atrial fibrillation (AFib) detection in remote cardiac monitoring of certain patients.

The company, which has offices in Paris and Boston, worked with Valley Health System of northern New Jersey to track a cohort of 425 patients who each received a Medtronic Reveal LINQ implantable loop recorder (ILR) for known AFib or cryptogenic stroke.

Researchers evaluated 1,500 AF episodes and annotated each as either true or false, according to the study, published in the Journal of the American College of Cardiology Clinical Electrophysiology.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0